Massachusetts Institute of Technology
Sign in

Introduction and Overview

06/07/2006 8:00 AM 46-3002
Susan Hockfield, President, MIT; ; Tyler Jacks, Director, David H. Koch Institute for Integrative Cancer Research and David H. Koch Professor, MITInvestigator, Howard Hughes Medical Institute;

Description: This inaugural address lays the groundwork for an 11-part series on MIT's efforts in cancer research. Susan Hockfield views MIT's Center for Cancer Research as a central example of how -life sciences are coming into conversation with engineering in a powerful way.” Robert Silbey provides historical background on the notion of faculty 'short courses', and positions the Center as -the jewel in the crown of MIT, a spawning ground for scientific discovery and rewards.” Tyler Jacks introduces the key research areas and scientists who will speak in the succeeding sessions. He offers a thumbnail sketch of cancer as a molecular genetic progression involving sequential alterations in, and the proliferation of, abnormal cells. -Think of a cancer cell like an integrated circuit: the same kinds of complexities in electronic networks also exist within cells,” notes Jacks. Because of work on the human genome, and advances in scientists' ability to untangle these complex molecular interactions, -We now have the first generation of anti-cancer drugs targeted against molecular alterations in cancer,” says Jacks. Two highly successful drugs have already been derived from MIT research. In addition, says Jacks, collaboration among biologists, engineers and mathematicians are yielding -a tremendous collection of tools and technologies.” These include tiny probes that enable diagnosis of cancers at earlier stages, nanoparticles that deliver a therapeutic payload directly to cancer cells, and devices that can be implanted in the body.

About the Speaker(s): Tyler Jacks received his A.B. in biology from Harvard College and his Ph.D. in Biochemistry and Biophysics from the University of California, San Francisco. His graduate work with Harold Varmus involved the mechanism of ribosomal frameshifting in retroviral gene expression. As a postdoctoral fellow with Robert Weinberg at the Whitehead Institute at MIT, Jacks initiated his studies on tumor-suppressor gene function, using gene targeting in the mouse. Jacks was named the 2005 Simon M. Shubitz Lecturer and Award recipient, and shared the 2005 Paul Marks Prize for Cancer Research awarded by Memorial Sloan-Kettering Cancer Center.

Host(s): School of Science, School of Science

Comments (0)

It looks like no one has posted a comment yet. You can be the first!

You need to log in, in order to post comments.

MIT World — special events and lectures

MIT World — special events and lectures

Category: Events | Updated over 1 year ago

Created
December 13, 2011 12:57
Category
Tags
License
All Rights Reserved (What is this?)
Additional Files


Viewed
4150 times

More from MIT World — special events and lectures

Rusnano: Fostering Nanotechnology Innovation in Russia

Rusnano: Fostering Nanotechnology I...

Added over 5 years ago | 00:51:54 | 13401 views

Traffic Paradoxes and Route Guidance: Effective Ways of Reducing Congestion Effects?

Traffic Paradoxes and Route Guidanc...

Added over 5 years ago | 00:58:18 | 20702 views

The Future of Civic Engagement in a Broadband"Enabled World

The Future of Civic Engagement in a...

Added over 5 years ago | 00:35:08 | 12086 views

Monitoring Dopamine Release During Reward Learning

Monitoring Dopamine Release During ...

Added over 5 years ago | 00:48:24 | 10608 views

Current Research IV

Current Research IV

Added over 5 years ago | 00:35:38 | 4523 views

Imaging the Human Striatum and its Modulation by Dopamine

Imaging the Human Striatum and its ...

Added over 5 years ago | 00:36:22 | 9080 views